Welcome to our dedicated page for Innovator International Developed Power Buffer ETF - November news (Ticker: INOV), a resource for investors and traders seeking the latest updates and insights on Innovator International Developed Power Buffer ETF - November stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Innovator International Developed Power Buffer ETF - November's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Innovator International Developed Power Buffer ETF - November's position in the market.
Inovalon (Nasdaq: INOV) has announced an exclusive partnership with Homecare Homebase to offer the EASE® All-Payer application, empowering over 25% of home health providers in the U.S. This cloud-based platform enhances patient data accuracy and administrative efficiency across all payers. The EASE® application boasts a 99% clean claims rate, benefiting providers through advanced analytics and real-time corrections for Medicare and commercial claims. This strategic move positions Inovalon as a key player in the data-driven healthcare landscape.
Inovalon (NASDAQ: INOV) announced the award of U.S. Patent No. 11,011,256 for its real-time patient-specific data analysis platform.
This patent enhances Inovalon's capabilities in Data-as-a-Service and Analytics-as-a-Service, facilitating on-demand healthcare analytics.
The Inovalon ONE® Platform utilizes this technology to address challenges in healthcare data accessibility and analytics, paving the way for improved patient care and operational efficiency.
Inovalon (NASDAQ: INOV) hosted its Virtual Investor Day on May 18, 2021, showcasing its growth strategy, market presence, and cloud-based platform capabilities. The event lasted approximately 2.5 hours and featured executives discussing the company’s vision and financial information. The presentation materials and a replay of the event will be available on their Investor Relations website.
Inovalon’s ONE® Platform supports over 25 leading health plans and pharmaceutical companies, leveraging extensive datasets to drive efficiency and improve healthcare outcomes.
Inovalon (Nasdaq: INOV) will participate in the 49th Annual J.P. Morgan Technology, Media and Communications Conference. CEO Keith Dunleavy, M.D., and CFO Jonathan R. Boldt will present in a fireside chat on May 25, 2021, at 11:00 a.m. ET. Investors can access the live webcast via the Investor Relations section of Inovalon’s website. The company offers cloud-based platforms for data-driven healthcare, leveraging the Inovalon ONE® Platform to provide insights and enhance care across the healthcare ecosystem for its extensive client base.
Inovalon (Nasdaq: INOV) has announced participation at the 16th Annual Needham Technology & Media Conference. Keith Dunleavy, CEO, and Jonathan R. Boldt, CFO, will present in a virtual fireside chat on May 19, 2021, at 2:15 p.m. ET. The presentation can be accessed via the Investor Relations section of Inovalon's website, with an archived version available for a limited time. Additionally, management will hold virtual one-on-one meetings with registered institutional investors throughout the day.
Inovalon (Nasdaq: INOV) will host a virtual Investor Day on May 18, 2021, starting at 10 a.m. ET. This 2.5-hour event will feature executives discussing the company's vision, growth strategy, markets, cloud-based platform capabilities, and financial information. The event will be webcast live, with a replay and presentation materials available afterward on their website. Inovalon is a leader in cloud-based healthcare data solutions, empowering insights to enhance care and operational efficiency across the healthcare ecosystem.
Inovalon reported Q1 2021 financial results with revenue of $177.2 million, a 15% year-over-year increase. Subscription-based revenue reached $158.0 million, representing 89% of total revenue. Net income was $9.2 million, or $0.06 per share. Non-GAAP net income was $25.0 million, up 55% YoY. Adjusted EBITDA surged to $58.6 million, a 23% increase. The company raised full-year revenue guidance to a growth range of 12% to 16% and provided optimistic Q2 guidance.
Inovalon (Nasdaq: INOV) will hold a conference call on April 28, 2021, at 5:00 p.m. ET to discuss its Q1 2021 financial results. The results will be released after market close on the same day. Investors can access the call by dialing (855) 783-2604 or (631) 485-4882 for international calls, using conference ID 3581518. A replay will be available on Inovalon's website. Inovalon provides cloud-based platforms for data-driven healthcare and serves a wide range of clients, including major health plans, pharma companies, and healthcare systems.
Inovalon (Nasdaq: INOV) announced the presentation of new data-driven research at various significant healthcare conferences. This research is powered by Inovalon’s MORE2 Registry®, which contains extensive real-world data on over 332 million patients. The MORE2 Registry® will be highlighted at meetings such as the AMCP Managed Care & Specialty Pharmacy Annual Meeting and the ISPOR Annual Meeting, focusing on healthcare costs and outcomes. This initiative aims to provide stakeholders with deeper insights into healthcare utilization and economic impacts.
FAQ
What is the current stock price of Innovator International Developed Power Buffer ETF - November (INOV)?
